After the September 11, 2001 terrorist attacks and the anthrax attacks that followed, a critical need arose: to develop and stockpile medical countermeasures (certain drugs and vaccines) needed to protect people from chemical, biological, radiological, nuclear (CBRN) and pandemic threats.